Summary
Objective
The primary objectives of the Cell Sorting competitive analysis include various Cell Sorting companies trying to differentiate themselves through advanced features, improved throughput, and integration with emerging technologies. These key companies also used various strategies, partnerships, and collaboration with research institutions to maintain a competitive edge.
Scope
The scope in the Cell Sorting competitive landscape encompasses the development of advanced sorting technologies, optimization of existing systems, and integration of advanced tools such as automation and AI. It involves continuous innovation to meet diverse research and clinical needs as well as strategic efforts to capture company share through cost-effective solutions and enhanced user interfaces.
Summary
The Global Cell Sorting Market size was valued at USD 664.09 million in 2023 and is expected to reach USD 1335.86 million by 2030 at a CAGR of 10.5% during the forecast period 2024-2030.
The competitive analysis provides a list of the top Global Cell Sorting companies that are focused on expanding their global reach using significant strategic initiatives such as regional expansion, product development, and strategic collaboration and partnership.
The competitive analysis of the cell-sorting market is characterized by a diverse range of Cell Sorting companies offering advanced technologies for accurate and efficient cell separation. Major key players in this industry such as Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Sony Biotechnology Inc., Miltenyi Biotec GmbH, and On-Chip Biotechnologies Co., Ltd. specialising in biotechnology and medical devices. These cell sorting companies are developing systems with enhanced accuracy, speed, and capacity to meet the growing demands of research and clinical applications. Strategic collaborations and partnerships play a significant role in the competitive landscape. Companies often collaborate with research institutions and other stakeholders to enhance their product offerings and gain access to new markets.
Bio-Rad Laboratories, Inc. is a leading Cell Sorting company that offers sorting services and products including S3e Cell Sorter and Fluorescence-Activated Cell Sorting. Bio-Rad’s S3e Cell Sorter is an easy-to-use cell sorter that is designed for fluorescence-activated cellular sorting. The company invests heavily in research and development to improve its cell sorting technology. Their strategy involves constantly improving the performance, sensitivity, and user-friendliness of their cell sorting systems. For instance, Bio-Rad’s improvements in flow cytometry, especially with its S3e Cell Sorter, reflect its commitment to innovation. This system boasts a compact design and excessive sorting performance providing to each small laboratories and large research facilities. In 2021 Bio-Rad acquired Singular Genomics which allowed Bio-Rad to integrate advanced genomics technology with its existing sorting solutions. Thus, strategic acquisitions play an essential role in Bio-Rad’s market strategy. By acquiring companies with complementary technology Bio-Rad enhances its product offerings and expands its technological abilities.
Sony Biotechnology Inc., headquartered in the United States is a leading player in the Cell Sorting market. The company plays a significant role in the Cell Sorting market through a strategic approach centred on advanced technology, revolutionary product improvement, strategic collaborations, and increasing global reach. Their top product, the SH800S Cell Sorter represents this strategy with its high-performance, compact design, and user-friendly interface. The SH800S functions with advanced optics and electronics which improve sorting accuracy and performance. The organization constantly invests in research and development to improve its cell sorting technologies. For instance, they have introduced new software capabilities that integrate seamlessly with their sorting structures offering researchers enhanced data analysis tools and improved workflow automation. The strategic collaborations and partnerships are vital to Sony Biotechnology’s market strategy. They actively collaborate with educational institutions, research centers, and other technology companies to improve their cell sorting solutions and discover new applications. Thus, Sony Biotechnology Inc.'s strategic focus on advanced generation, non-stop innovation, strategic partnerships, and global enlargement has maintained its position as a leading player in the cell sorting market.
Becton, Dickinson and Company is one of the largest global medical technology companies in the world and advancing the world of health by improving medical discovery, diagnostics, and the delivery of care. BD’s strategy in the cell sorting market is driven by technological innovation and product excellence. Their BD FACSAria III and BD FACSymphony systems show this approach, offering advanced flow cytometry solutions with high-resolution capabilities and multi-color analysis. These systems are designed to meet the demanding needs of both research and clinical applications. BD’s growth strategy includes strategic acquisitions that enhance its technological portfolio and market reach. In 2021, BD acquired Cytognos company that specializes in specialized flow cytometry reagents and software. This acquisition has strengthened BD’s position in the cell sorting market by integrating Cytognos’s expertise and increasing BD’s product services.
Recent Developments in the Cell Sorting Market:
• In Oct 2023, Sony launched the FP7000 spectral cell sorter which offers high-speed, high-parameter sorting with over 44 colors. The device can be configured with up to 6 lasers and 182 detectors and supports multiple nozzle sizes for optimized sorting. Its high-speed, real-time spectral unmixing capability enables up to 6-way sorting at 25,000 events per second.
• In Mar 2024, Bio-Rad Laboratories launched validated antibodies for rare cell and circulating tumor cell enumeration, specifically targeting CTC surface markers. These antibodies enhance the study of tumor heterogeneity and disease progression.
Table of Content
1. Cell Sorting Market Competition Matrix
a. Market Structure
i. Market Leaders
ii. Market Followers
iii. Emerging Players
2. Competitive Benchmarking of key players
3. Mergers and Acquisition in Pine Derived Chemicals
4. Cell Sorting Manufacturing Company Profile: Key Players
4.1 Bio-Rad Laboratories, Inc.
a. Company Overview
b. Financial Overview
c. Product Portfolio
d. SWOT Analysis
e. Business Strategy
f. Recent Developments
4.2. Becton, Dickinson and Company
4.3. Bay Bioscience Co., Ltd
4.4. Beckman Coulter, Inc.
4.5. Sony Biotechnology Inc.
4.6. Miltenyi Biotec GmbH
4.7. On-Chip Biotechnologies Co., Ltd.
4.8. Cytonome/St, LLC
4.9. Union Biometrica, Inc.
4.10. Thermo Fisher Scientific, Inc.
4.11. Affymetrix Inc.
4.12. Sysmex Partec GmbH
4.13. Danaher Corporation
4.14. Stemcell Technologies Inc
4.15. Terumo BCT, Inc. (A Subsidiary of Terumo Corporation)
4.16. Abgenex
5. Key Findings
